CHRISTOPHER THOMAS: Open Payments
NPI 1821676701 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 42 payments from 13 companies in 2025. Trend: 2023 $483 · 2024 $497 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $194 |
| ABBVIE INC. | 10 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $95 |
| Novo Nordisk Inc | 4 | $65 |
| Lilly USA, LLC | 3 | $49 |
| Viatris Specialty LLC | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Exact Sciences Corporation | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $19 |
Products named: VRAYLAR, CAPLYTA, FARXIGA, BREZTRI, Wegovy, AIRSUPRA, YUPELRI, REXULTI.
Industry payments across KY — which companies pay providers there.
